Carcinoid syndrome, unspecified
ICD-10 E34.00 is a billable code used to indicate a diagnosis of carcinoid syndrome, unspecified.
Carcinoid syndrome is a complex of symptoms that arise from the secretion of serotonin and other vasoactive substances by neuroendocrine tumors, primarily carcinoid tumors. These tumors are most commonly found in the gastrointestinal tract, particularly the small intestine, but can also occur in the lungs and other sites. The syndrome is characterized by flushing, diarrhea, wheezing, and abdominal pain. Patients may also experience cardiac complications, such as carcinoid heart disease, which can lead to valvular dysfunction. The symptoms can vary widely among patients, and the diagnosis often requires a combination of clinical evaluation, biochemical tests (such as serum serotonin levels), and imaging studies. The unspecified designation indicates that the specific type or site of the carcinoid tumor has not been determined, which can complicate management and treatment strategies. Understanding the underlying pathophysiology is crucial for effective treatment, which may include surgical resection, somatostatin analogs, and targeted therapies.
Detailed documentation of tumor type, location, and treatment plan.
Patients presenting with gastrointestinal symptoms and a known history of neuroendocrine tumors.
Ensure that all relevant imaging and lab results are included in the documentation.
Comprehensive hormonal assessment and symptom tracking.
Patients with flushing and diarrhea who have elevated serotonin levels.
Document any hormonal therapies or interventions that may affect symptom management.
Used when a biopsy is performed to confirm the presence of a carcinoid tumor.
Pathology report must be included in the patient's medical record.
Oncology specialists should ensure that all relevant tumor characteristics are documented.
Common symptoms include flushing, diarrhea, wheezing, and abdominal pain, often due to the secretion of serotonin and other vasoactive substances by carcinoid tumors.